Breaking News Instant updates and real-time market news.

CTIC

CTI BioPharma

$0.81

0.0067 (0.83%)

16:09
11/04/19
11/04
16:09
11/04/19
16:09

CTI BioPharma reports Q3 EPS (17c), consensus (23c)

Reports Q3 revenue $2.29M. Reports Q3 operating loss $9.7M. The company commented, "We advanced our pacritinib development program in the third quarter, and recently took an important step forward for the company by initiating and enrolling the first patient in the PACIFICA trial, our pivotal Phase 3 trial of pacritinib in myelofibrosis patients with severe thrombocytopenia. An estimated one-third of patients with myelofibrosis are severely thrombocytopenic - a population with limited therapeutic options and poor survival, thereby making this disease setting a very important area of unmet medical need. In the near-term, we look forward to presenting results from the PAC203 Phase 2 trial at a scientific conference before the end of the year."

  • 07

    Dec

CTIC CTI BioPharma
$0.81

0.0067 (0.83%)

03/05/19
LSCM
03/05/19
INITIATION
Target $4
LSCM
Buy
CTI BioPharma initiated with a Buy at Lake Street
Lake Street analyst Thomas Flaten started CTI BioPharma with a Buy rating and $4 price target. The company's targeted indication for pacritinib in myelofibrosis with severe thrombocytopenia represents an unmet clinical need and potential revenue opportunity of $450M, Flaten tells investors in a research note. Further, CTI's other compounds are not being developed for this niche indication, providing a "substantial pay-off" for the company should the clinical development of pacritinib bear fruit, says the analyst.
08/19/19
LSCM
08/19/19
NO CHANGE
Target $4
LSCM
Buy
Celgene's fedratinib approval 'positive signal' for CTI Bio, says Lake Street
Lake Street analyst Thomas Flaten affirmed a Buy rating and $4 price target for CTI BioPharma (CTIC) after Celgene (CELG) announced on Friday approval of its myelofibrosis drug, fedratinib. Flaten tells investors in a research note that he views view fedratinib's approval as a positive signal for CTI, the development of pacritinib and the opportunity for CTI to own the MF patients population with severe thrombocytopenia.

TODAY'S FREE FLY STORIES

XLU

Utilities SPDR

$62.98

-0.005 (-0.01%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$62.52

-0.24 (-0.38%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$304.54

2.52 (0.83%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Conference/Events
Cooper Companies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

XLV

Health Care Select Sector SPDR

$99.86

0.14 (0.14%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$162.58

0.11 (0.07%)

08:22
12/11/19
12/11
08:22
12/11/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$39.07

-0.97 (-2.42%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Recommendations
HD Supply analyst commentary  »

HD Supply price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$279.48

-0.26 (-0.09%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNQ

Canadian Natural

$29.51

0.4524 (1.56%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Upgrade
Canadian Natural rating change  »

Canadian Natural upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLF

Financial Select Sector

$30.28

(0.00%)

08:21
12/11/19
12/11
08:21
12/11/19
08:21
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$133.61

0.51 (0.38%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$203.90

-0.13 (-0.06%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$68.90

-0.73 (-1.05%)

, T

AT&T

$38.07

0.025 (0.07%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Conference/Events
Barclays to hold a conference »

Global Technology, Media…

LITE

Lumentum

$68.90

-0.73 (-1.05%)

T

AT&T

$38.07

0.025 (0.07%)

GLW

Corning

$28.00

-0.5 (-1.75%)

AIC

Aames Investment

$23.46

0.055 (0.24%)

AMD

AMD

$39.44

0.53 (1.36%)

NOW

ServiceNow

$266.94

-2.95 (-1.09%)

ADSK

Autodesk

$178.50

-0.28 (-0.16%)

PEGA

Pegasystems

$75.42

-0.81 (-1.06%)

TXN

Texas Instruments

$121.38

-0.61 (-0.50%)

ALRM

Alarm.com

$41.80

-1.11 (-2.59%)

ESTC

Elastic

$62.46

0.32 (0.51%)

FICO

Fair Isaac

$354.61

-4.75 (-1.32%)

RVLV

Revolve Group

$17.02

-0.14 (-0.82%)

ZS

Zscaler

$46.10

-1.24 (-2.62%)

MOBL

MobileIron

$4.54

-0.045 (-0.98%)

AVLR

Avalara

$72.00

-0.84 (-1.15%)

VMW

VMware

$148.73

-0.78 (-0.52%)

CCC

Clarivate Analytics

$16.90

-0.17 (-1.00%)

MSFT

Microsoft

$151.18

-0.17 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 08

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Mar

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:20
12/11/19
12/11
08:20
12/11/19
08:20
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PMBC

Pacific Mercantile Bancorp

$7.19

0.06 (0.84%)

08:19
12/11/19
12/11
08:19
12/11/19
08:19
Hot Stocks
Pacific Mercantile Bank provides financing to Mako Steel »

Pacific Mercantile Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$84.11

-0.83 (-0.98%)

, AAPL

Apple

$268.62

1.69 (0.63%)

08:18
12/11/19
12/11
08:18
12/11/19
08:18
Recommendations
Qualcomm, Apple analyst commentary  »

BofA says Apple could…

QCOM

Qualcomm

$84.11

-0.83 (-0.98%)

AAPL

Apple

$268.62

1.69 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

DARE

Dare Bioscience

$0.80

-0.0087 (-1.08%)

08:15
12/11/19
12/11
08:15
12/11/19
08:15
Hot Stocks
Dare announces alignment with FDA on Phase 2b study of Sildenafil Cream »

Dare Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
12/11/19
12/11
08:15
12/11/19
08:15
General news
CPI to be reported at 08:30 »

November CPI will be…

08:15
12/11/19
12/11
08:15
12/11/19
08:15
General news
CPI less food & energy- to be reported at 08:30 »

November CPI less food…

ITRM

Iterum Therapeutics

$4.90

1.1 (28.95%)

08:14
12/11/19
12/11
08:14
12/11/19
08:14
Recommendations
Iterum Therapeutics analyst commentary  »

Iterum Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$13.70

-0.685 (-4.76%)

08:14
12/11/19
12/11
08:14
12/11/19
08:14
Conference/Events
Yext management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

KLR

Kaleyra

$8.49

0.03 (0.35%)

08:11
12/11/19
12/11
08:11
12/11/19
08:11
Initiation
Kaleyra initiated  »

Kaleyra initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WINT

Windtree Therapeutics

$0.00

(0.00%)

08:11
12/11/19
12/11
08:11
12/11/19
08:11
Conference/Events
Windtree Therapeutics to hold a financial update »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTM

Constellium

$14.50

0.06 (0.42%)

08:11
12/11/19
12/11
08:11
12/11/19
08:11
Hot Stocks
Constellium's Singen facility to offer ASI certified aluminum rolled solutions »

Constellium SE announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.